[1]田 丽,刘 京,李艳青,等.完带汤加减对HPV感染合并低度宫颈上皮内瘤变患者疾病转归及局部炎症的影响[J].陕西中医,2023,(1):33-36.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.008]
　TIAN Li,LIU Jing,LI Yanqing,et al.Influence of modified Wandai decoction for disease outcome and local inflammation of patients with HPV infection complicated with low-grade cervical intraepithelial neoplasia[J].,2023,(1):33-36.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.008]
点击复制

完带汤加减对HPV感染合并低度宫颈上皮内瘤变患者疾病转归及局部炎症的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年1期
页码:
33-36
栏目:
临床研究
出版日期:
2023-01-05

文章信息/Info

Title:
Influence of modified Wandai decoction for disease outcome and local inflammation of patients with HPV infection complicated with low-grade cervical intraepithelial neoplasia
作者:
田 丽1; 刘 京2; 李艳青2; 褚键子2; 杨子娇2; 陈 贤2
(1.石家庄市中医院手术室,河北 石家庄 050011; 2.河北省中医院,河北 石家庄 050013)
Author(s):
TIAN Li; LIU Jing; LI Yanqing; CHU Jianzi; YANG Zijiao; CHEN Xian
(Operation Room,Hospital of Traditional Chinese Medicine of Shijiazhuang City,Shijiazhuang 050011,China)
关键词:
低度宫颈上皮内瘤变;  完带汤加减;  HPV感染;  疾病转归;  阴道灌洗液;  局部炎症
Keywords:
Low-grade cervical intraepithelial neoplasia;  Modified Wandai decoction;  HPV infection;  Disease outcome;  Vaginal lavage liquid;  Local inflammation
分类号:
R 711.74
DOI:
DOI:10.3969/j.issn.1000-7369.2023.01.008
文献标志码:
A
摘要:
目的:探究完带汤加减对人乳头瘤病毒(HPV)感染合并低度宫颈上皮内瘤变患者疾病转归及局部炎症的影响。方法:将80例HPV感染合并低度宫颈上皮内瘤变患者根据随机数字表法分为两组,每组40例。对照组进行HPV感染合并低度宫颈上皮内瘤变的常规西医治疗,观察组则在对照组治疗的基础上采用完带汤加减治疗。比较两组的治疗总有效率、HPV转阴率、治疗前后的中医证候积分、局部炎症相关指标阴道灌洗液防御素[β-防御素-2(HBD-2)及防御素-5(HD-5)]及阴道灌洗液炎症因子[肿瘤坏死因子-α(TNF-α)、白介素-1β(IL-1β)及白介素-6(IL-6)]。结果:观察组的治疗总有效率及治疗后3个月、6个月的HPV转阴率分别为77.50%,55.00%及75.00%,高于对照组的37.50%,30.00%及47.50%(P<0.05); 治疗后两组的上述中医证候积分、阴道灌洗液防御素、阴道灌洗液炎症因子均低于治疗前,且观察组的积分及阴道灌洗液指标显著低于对照组(P<0.05)。结论:完带汤加减在HPV感染合并低度宫颈上皮内瘤变患者中的应用效果较好,可有效改善患者的疾病转归及控制局部炎症。
Abstract:
Objective:To investigate the influence of modified Wandai decoction for disease outcome and local inflammation of patients with HPV infection complicated with low-grade cervical intraepithelial neoplasia.Methods:80 patients with HPV infection complicated with low-grade cervical intraepithelial neoplasia were divided into control group and observation group with 40 cases in each group according to the method of random number table.The control group were treated with routine western medicine treatment,the observation group were treated with modified Wandai decoction on the treatment of control group.Then the total effective rates,HPV negative rates,TCM syndrome integral and local inflammation related indexes vaginal lavage liquid defensins [β-Defensin-2(HBD-2)and Defensin-5(HD-5)] and inflammatory factors[tumor necrosis factor-α(TNF-α),Interleukin-1β(IL-1β)and interleukin-6(IL-6)]before and after the treatment of two groups were compared.Results:The total effective rates and HPV negative rates at third and sixth month after the treatment of observation group were respectively 77.50%,55.00% and 75.00%,and they were higher than 37.50%,30.00% and 47.50% of control group(P<0.05); the TCM syndrome integral,vaginal lavage liquid defensinsand inflammatory factors of two groups after the treatment were higher than those before the treatment,and the integral and vaginal lavage liquid indexes of observation group were significantly lower than those in control group(P<0.05).Conclusion:The application effect of modified Wandai decoction in the treatment of patients with HPV infection complicated with low-grade cervical intraepithelial neoplasia is better,and it can effectively improve the disease outcome and control the local inflammation of patients.

参考文献/References:

[1] 王欢欢,李 萍,徐亚平.影响高级别宫颈上皮内瘤变患者术后人乳头瘤病毒感染持续阳性的相关因素调查研究[J].中国妇幼保健,2019,34(21):5021-5023.
[2] 陈 丽,何群双.重组人干扰素α-2b栓联合微波治疗宫颈上皮内瘤变Ⅰ级合并高危HPV阳性的疗效[J].中国现代药物应用,2021,15(11):130-132.
[3] 秦 丽,朱 莉,王瑞雅,等.宫颈阴道微生物群与HPV感染,宫颈上皮内瘤变及宫颈癌的关系:系统评价和网络荟萃分析[J].临床医学进展,2021,11(2):698-713.
[4] 李 姣,刘超萍.完带汤联合重组人干扰素α-2b治疗持续高危型HPV感染疗效及对淋巴细胞亚群的影响研究[J].现代中西医结合杂志,2020,29(14):1557-1560.
[5] 侯明慧,刘文娥,伍彩霞,等.活用完带汤治疗人乳头瘤病毒感染经验总结[J].中医药临床杂志,2020,32(8):1443-1446.
[6] 陈丹华,王乃平,侯晓萍,等.萆薢完带汤治疗高危型HPV感染脾虚气滞患者的临床研究[J].中国处方药,2022,20(6):77-79.
[7] 邢海燕,徐丽霞,张小月,等.清湿热益肾解毒汤联合冷冻治疗对持续性宫颈上皮内瘤变的影响[J].陕西中医,2017,38(6):738-740.
[8] 张送萍,尹凌凡,毕艳慧.宫颈高危型人乳头瘤病毒感染与阴道菌群及血清氧化应激水平关系探讨[J].陕西医学杂志,2020,49(8):975-978,1028.
[9] 苏 航,范 雪,艾 浩.不同生育期女性高危型HPV感染调查及相关危险因素分析[J].陕西医学杂志,2021,50(8):1023-1026.
[10] 胡国敏,冯丽君,王立锋.高危型HPV感染与阴道微生态及宫颈局部细胞免疫相关性研究[J].陕西医学杂志,2019,48(11):1447-1449,1528.
[11] 曾 妍.氟康唑口服联合克霉唑栓及乳酸杆菌阴道用药治疗外阴阴道假丝酵母菌病对阴道分泌物中抗菌肽LL-37、防御素5水平的影响观察[J].中国医学创新,2021,18(17):135-139.
[12] Gulati NM,Miyagi M,Wiens ME,et al.α-Defensin HD5 stabilizes human papillomavirus 16 capsid/core interactions[J].Pathog Immun,2019,4(2):196-234.
[13] 巢世兰,李玉琴,阿祥仁,等.生殖道感染孕妇阴道分泌物中人β防御素表达水平及临床意义[J].中华医院感染学杂志,2021,31(21):3327-3331.
[14] Albosale AH,Mashkina EV.Association between promoter polymorphisms of IL-1β,IL-4 and IL-6 Genes and a viral load infected women with human papillomavirus[J].J Reprod Infertil,2021,22(2):92-102.
[15] 杨广丽.阴道灌洗液中IL-6、IL-17、IFN-γ、TGF-β检测在宫颈高危型HPV感染患者中的临床意义[J].中国现代医学杂志,2020,22(7):23-26.
[16] 唐阳芳,张少华,栾丽霞,等.高危型人乳头瘤病毒阳性、细胞学检查阴性患者感染不同类型高危型人乳头瘤病毒与宫颈高级别鳞状上皮内病变相关性研究[J].陕西医学杂志,2022,51(8):978-981,1012.
[17] 夏金多,吕春亮,闫 萍,等.清热通利汤对宫颈炎并HPV感染患者生化指标与临床症状的影响研究[J].陕西中医,2020,41(11):1607-1610.
[18] 谢 伟.IL-1β、TLR3、NF-κB在宫颈癌及宫颈上皮内瘤变中的表达及相关性研究[J].陕西医学杂志,2018,47(2):150-152.
[19] Traore IMA,Zohoncon TM,Djigma FW,et al.Association of TNF-α-308G/A and IL-18 polymorphisms with risk of HPV infection among sexually active women in Burkina Faso[J].Biomol Concepts,2020,11(1):97-101.
[20] 袁亚美,朱文莉,施 慧.完带汤对肝郁脾虚型慢性宫颈炎模型大鼠病理形态及阴道微生态的影响[J].陕西中医药大学学报,2018,41(3):85-88.
[21] 贺 雯,任琛琛,杨 立,等.阴道灌洗液中TNF-α、IL-12、IL-10表达与高危型HPV持续感染的相关性[J].现代妇产科进展,2019,28(2):86-89.
[22] 吴 燕.干扰素联合微波治疗对宫颈炎合并HPV感染患者炎症反应及免疫细胞功能的影响[J].河南外科学杂志,2020,26(5):97-98.
[23] 耿 放,王艾平,陈 芳,等.人乳头瘤病毒假病毒体外感染模型的建立及人α防御素5抗病毒作用[J].第三军医大学学报,2012,34(6):473-476.
[24] 戎凤敏,秦海霞,张景航,等.宫颈病变患者外周血免疫球蛋白及阴道灌洗液中免疫细胞因子水平变化及临床意义[J].实验与检验医学,2021,39(3):599-602.
[25] 陈 飞.高危型HPV感染与阴道局部防御素表达关系[D].郑州:郑州大学,2019.

备注/Memo

备注/Memo:
基金项目:河北省中医药管理局科研计划项目(2021005)
更新日期/Last Update: 2022-12-28